Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement

M Gawaz; M Seyfarth; I Müller; S Rüdiger; G Pogatsa-Murray; B Wolf; A Schömig

doi:10.1016/s0002-9149(00)01369-2

Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement

Am J Cardiol. 2001 Feb 1;87(3):332-6, A9. doi: 10.1016/s0002-9149(00)01369-2.

Authors

M Gawaz¹, M Seyfarth, I Müller, S Rüdiger, G Pogatsa-Murray, B Wolf, A Schömig

Affiliation

¹ Medizinische Klinik, Klinikum rechts der Isar und Deutsches Herzzentrum, Technische Universität München, Germany. gawaz@dhm.mhn.de

PMID: 11165971
DOI: 10.1016/s0002-9149(00)01369-2

Abstract

Clopidogrel in combination with aspirin administered as a loading dose of 450 mg reveals an accelerated antiplatelet effect in the early hours after first administration in patients undergoing coronary stent placement.

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Angioplasty, Balloon, Coronary
Clopidogrel
Coronary Disease / blood
Coronary Disease / therapy*
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors / administration & dosage*
Platelet Aggregation Inhibitors / adverse effects
Platelet Function Tests*
Prospective Studies
Recurrence
Stents*
Ticlopidine / administration & dosage*
Ticlopidine / adverse effects
Ticlopidine / analogs & derivatives*

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine